MedaSync Gains Strategic Investment from Omega Healthcare

August 28, 2025
MedaSync has secured a strategic investment from Omega Healthcare Investors, Inc., to accelerate the growth of its AI-powered reimbursement software for skilled nursing facilities.

MedaSync has secured a strategic investment from Omega Healthcare Investors, Inc., a leading real estate investment trust focused on skilled nursing and assisted living facilities. This investment, announced in a press release, aims to accelerate the adoption of MedaSync's AI-powered reimbursement optimization software, which is designed to reduce administrative burdens in the skilled nursing sector.

MedaSync's platform uses AI to analyze clinical documentation, surfacing reimbursement misalignments and identifying patient needs to ensure high-quality care. The company has seen significant growth, with customer acquisition increasing over 100% year-over-year. As part of the investment, Megan Krull, Senior Vice President of Operations at Omega Healthcare, will join MedaSync's Board of Directors.

The funding will support MedaSync in scaling its innovative SaaS products and expanding its market presence, providing skilled nursing organizations with tools to navigate the complex reimbursement landscape effectively.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

AI Funding News Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Funding

08/29
TurnKey Lender Secures Investment for AI Innovation and Expansion
08/29
Toppi Secures €1 Million to Expand AI Solutions in Hospitality
08/29
OPTEL Group Acquires Vanguard Robotics to Boost Pharma Automation
08/28
Lovable Attracts $4 Billion Valuation Amid Investor Interest
08/28
CrowdStrike Acquires Onum to Enhance Real-Time Threat Detection

More from: Life Sciences

08/29
IQSTEL Partners with Mobility Tech for AI Call Center Solutions
08/29
OPTEL Group Acquires Vanguard Robotics to Boost Pharma Automation
08/28
Fujitsu Unveils AI Agent Platform for Healthcare Efficiency
08/28
BranchLab Appoints Dan Parkes as CTO
08/28
Argent BioPharma Acquires AusCann Group's Key Assets

Subscribe to AI Funding Brief

AI Token Webinar

Market report

AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation

ModelOp

The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.

Read more

You May Also Like